Connect with us

Hi, what are you looking for?

Latest News

The White House has a pharmacy – and it was a mess, a new investigation found

Join Fox News for access to this content
Plus get unlimited access to thousands of articles, videos and more with your free account!
Please enter a valid email address.
By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your email and follow the instructions provided.

A new Defense Department inspector general report reveals that a little-known in-house pharmacy at the White House erroneously dolled out prescription medications to staff and wasted $750,000 in taxpayer money.

One former pharmacy staff member told investigators that a doctor once asked if the staffer could ‘hook up’ someone with a controlled substance ‘as a parting gift for leaving the White House.’

The report, according to an article in Stat News, revealed that the pharmacy office dispensed controlled medications like Ambien and Provigil without verifying the patient’s identity.

Stat reported that in an office in the White House there was a sign that read ‘Pharmacy,’ but the people in charge of it insisted it wasn’t actually one.

The investigation, which was published this month, was conducted by the Department of Defense’s independent Office of the Inspector General as the White House pharmacy is run by the White House Military Office and its associated medical unit.

The probe was prompted by internal complaints the DOD received in 2018 about a senior military medical officer, who is not named, engaging in ‘improper medical practices.’ It covers only activity in the office through early 2020 under the Trump administration, but investigators interviewed staffers who also worked there under former President Obama, according to Stat.

According to the report, the ‘pharmacy’ let people grab over-the-counter medicines from open bins.

It also found that a larger affiliate of the office inappropriately covered care for a whole host of personnel who weren’t eligible, costing more than $750,000 in wasted taxpayer funds in just three years. Stat notes that even that number is ‘fuzzy’ because so many records were poorly kept and even handwritten.

‘If this had been a traditional pharmacy, they certainly would have been cited by their state board of pharmacy,’ Douglas Hoey, CEO of the National Community Pharmacists Association, told the outlet. ‘And there’s probably even an outside chance that they’d be shut down by their state board of pharmacy, if this was a pharmacy operating outside of the cocoon of the White House.’.

This post appeared first on FOX NEWS

You May Also Like

Editor's Pick

Real gross domestic product rose at a revised 3.2 percent annualized rate in the third quarter versus a 0.6 percent rate of decline in...

Editor's Pick

In Risky Business: Why Insurance Markets Fail and What to Do About It (Yale University Press, 2023), economists Liran Einav (Stanford), Amy Finkelstein (MIT),...

Editor's Pick

For years the North Korean playbook was obvious to the world. The Democratic People’s Republic of Korea wanted to be the center of attention....

Editor's Pick

After the final lecture of my Fall 2022 International Economic Policy course (an undergraduate offering meant to introduce non-economics majors to the economics of...



Disclaimer: impactofincome.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2023 impactofincome.com